In situ IL-12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli.
about
BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAMlow CD11bhigh Skin Dendritic cells to Draining Lymph Node During CD4+ T-Cell PrimingThe glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCGMycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages.Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell primingTLR-2 independent recognition of Mycobacterium tuberculosis by CD11c+ pulmonary cells from old miceBeyond macrophages: the diversity of mononuclear cells in tuberculosis.IL12Rβ1: the cytokine receptor that we used to know.IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes.Chronic Gastrointestinal Nematode Infection Mutes Immune Responses to Mycobacterial Infection Distal to the Gut.Outrunning the Red Queen: bystander activation as a means of outpacing innate immune subversion by intracellular pathogens.Immunogenicity is preferentially induced in sparse dendritic cell cultures.Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.MyD88 signalling in myeloid cells is sufficient to prevent chronic mycobacterial infection.STAT3 expression by myeloid cells is detrimental for the T- cell-mediated control of infection with Mycobacterium tuberculosis.Langerin+ CD8α+ Dendritic Cells Drive Early CD8+ T Cell Activation and IL-12 Production During Systemic Bacterial Infection.
P2860
Q27317092-C4D191A1-4D2A-47D2-AC90-53BDF950ACD3Q33748947-3C561D7B-AF7B-46AC-975F-1AF5BEEA4A62Q33848355-C87B2A9F-0EAE-488B-9189-DC28279A6658Q33902489-F1E69DAA-D7EA-414A-8C40-BCBBF84ACDD4Q34012264-E15E78C1-95AB-4074-8BC8-431387D9DF12Q34372502-16424813-AFDA-4BA1-8B01-2A9AE88CC1F3Q35136546-77AEEBF4-2DAC-42D6-A478-8D39CEE329AAQ35551021-044403FA-B5D1-4025-AE6F-704E2449D261Q36358157-DB0F8EC5-B9E8-4CB7-98CA-039ACC7A00AFQ36446942-EAC10299-6661-4524-9E7E-F6DFFF569F5FQ36597276-0659ADA9-F426-41F9-BE3B-94F7C6AFDDDAQ37559681-2B029D31-0F0E-42D4-860E-87ADD7C53F57Q37690509-21C3707A-8F3E-47D4-83AA-1C9A42E3C604Q39652806-E1CF806F-6654-4527-97DE-20CA7974AA44Q42232540-36C65B83-CB1A-4E7C-8C81-0D96358858BEQ48235101-F94BFDD6-9669-4DD7-BAEF-E2615BAF4C9CQ55527143-24FCB936-5E6F-4E14-B1EB-86B71EC9AF41
P2860
In situ IL-12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In situ IL-12/23p40 production ...... from those harboring bacilli.
@en
In situ IL-12/23p40 production ...... from those harboring bacilli.
@nl
type
label
In situ IL-12/23p40 production ...... from those harboring bacilli.
@en
In situ IL-12/23p40 production ...... from those harboring bacilli.
@nl
prefLabel
In situ IL-12/23p40 production ...... from those harboring bacilli.
@en
In situ IL-12/23p40 production ...... from those harboring bacilli.
@nl
P2093
P2860
P50
P356
P1476
In situ IL-12/23p40 production ...... t from those harboring bacilli
@en
P2093
Andre Bafica
Richard M Locksley
P2860
P304
P356
10.4049/JIMMUNOL.0900074
P407
P577
2009-06-01T00:00:00Z